A NIR-II fluorescent photosensitizer with aggregation-induced reactive oxygen efficiency enhancement characteristics and its application
By designing the compound AS4Se and its nanoparticle form, the non-planar conformation is introduced using selenophenyl groups, the problem of insufficient ROS efficiency in the aggregated state of NIR-II fluorescent photosensitizer is solved, efficient ROS generation and fluorescence enhancement are achieved, and the The effect of photodynamic therapy.
Patent Information
- Application Number
- CN202411252928.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-09
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-09-09
AI Technical Summary
The existing NIR-II fluorescent photosensitizers have insufficient ROS efficiency in the aggregated state, resulting in ROS quenching, limiting their photodynamic therapeutic effect in the long excitation wavelength region.
Design a compound AS4Se, which has the A-D-A'-D-A structural backbone and the peripheral selenophenyl group, prepares AS4Se NPs by nanocoprecipitation method, introduces non-planar conformations using selenophenone units to enhance aggregation-induced fluorescence and ROS efficiency .
AS4Se NPs significantly enhance ROS efficiency in the aggregation state, overcome the ROS quenching effect, exhibit high NIR-II fluorescence brightness and excellent type I and type II photodynamic performance, and improve the effectiveness of tumor optical diagnosis and treatment.
Smart Images

Figure CN118754897B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of optical diagnosis and treatment, and relates to the design, synthesis and application of a near-infrared second-zone fluorescent photosensitizer. Background Art
[0002] Optical diagnostics and treatment technology that combines near-infrared-II (NIR-II, 1000-1700 nm) fluorescence imaging with photodynamic therapy (PDT) is a cutting-edge method for tumor diagnosis and treatment. Under photon excitation, near-infrared second window (NIR-II) fluorescent photosensitizers transition from the ground state to a short-lived excited singlet state. The excited photosensitizer may return to the ground state by emitting NIR-II fluorescence, a property that enables accurate and sensitive diagnosis of tumors and helps determine when and where to perform photodynamic therapy (PDT); or undergo intersystem crossing (ISC) to form a relatively long-lived excited triplet state, which can directly interact with the substrate, leading to the generation of reactive oxygen species (ROS), thereby destroying tumor tissue. Based on the principles of photophysics and photochemistry, PDT can work through type I and type II mechanisms. Type I PDT involves the interaction of photosensitizers with substrates to form short-lived free radicals through electron transfer or hydrogen atom abstraction. These free radicals immediately react with water, oxygen, or other molecules to produce hydroxyl radicals (•OH), superoxide radicals (O2 •− ) or hydrogen peroxide (H2O2). Type II PDT involves the conversion of photosensitizers in the T1 state to molecular oxygen ( 3 O2) to produce cytotoxic singlet oxygen ( 1 O2). Compared with type II PDT, which mainly relies on oxygen, type I PDT is less dependent on oxygen because it can make use of disproportionation reaction, Fenton reaction or Haber-Weiss reaction to compensate for oxygen consumption. Therefore, type II PDT shows significant therapeutic effects on tumors under normal oxygen conditions, while type I PDT shows better therapeutic effects in hypoxic tumors. Considering the presence of heterogeneous oxygen concentrations in most solid tumors, especially many hypoxic areas, the development of NIR-II fluorescent photosensitizers with good both type I and type II photodynamic properties will help improve the effectiveness of in vivo PDT, because these photosensitizers can effectively eliminate tumor cells in both normal oxygen and hypoxic areas through type II or type I mechanisms.
[0003] Unfortunately, obtaining NIR-II fluorescent photosensitizers with both high NIR-II brightness and superior type I / II photodynamic properties is a major challenge. This challenge is particularly severe in those photosensitizers that can be excited in the longer wavelength region (e.g., above 800 nm). A major obstacle is the quenching phenomenon caused by fluorescence and ROS aggregation due to unfavorable π-π stacking. A potential approach to address this problem is to design NIR-II fluorescent photosensitizer molecules that exhibit improved fluorescence and photodynamic properties upon aggregation. Previous studies have shown that certain fluorescent photosensitizers have aggregation-induced emission properties, which facilitates the generation of bright nanophosphors and displays enhanced ROS generation capabilities upon aggregation. However, this phenomenon is mainly observed in photosensitizers with visible light absorption and emission properties, and has not been widely observed in NIR-II fluorescent photosensitizers with long excitation wavelengths, limiting their potential for in vivo applications. Therefore, there is an urgent need to develop novel fluorescent molecules that can simultaneously enhance ROS generation and fluorescence efficiency in the aggregated state to produce NIR-II fluorescent photosensitizers with the above-mentioned therapeutic properties. Summary of the invention
[0004] The technical problem solved by the present invention is: to propose a NIR-II fluorescent photosensitizer with aggregation-induced reactive oxygen efficiency enhancement characteristics and its application in tumor optical diagnosis and treatment. The compound AS4Se is used to prepare a near-infrared second-zone fluorescent photosensitizer, which overcomes the problems of insufficient ROS efficiency, generation of a single type of ROS, and short excitation wavelength of existing NIR-II fluorescent photosensitizers in the aggregated state. AS4Se can enhance ROS efficiency when aggregated and can overcome the ROS quenching effect caused by aggregation.
[0005] In order to solve the above technical problems, the technical solution proposed by the present invention is: a compound, the structural formula of the compound AS4Se is as follows:
[0006]
[0007] In order to solve the above technical problems, another technical solution proposed by the present invention is: the synthesis route of compound AS4Se is as follows:
[0008]
[0009] Reagents and conditions used in the synthesis route of AS4Se: i) 2-(4,7-dibromo-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile, pyridine, chloroform, 56°C, 10h; ii) (selenopyridine-2-yl)tributylstannane, tris(dibenzylideneacetone)dipalladium(0), tris(o-methylphenyl)phosphine, toluene, 100°C, 5h.
[0010] In order to solve the above technical problems, another technical solution proposed by the present invention is: a NIR-II fluorescent photosensitizer with aggregation-induced reactive oxygen efficiency enhancement characteristics prepared by the compound, the compound AS4Se is used to prepare a near-infrared II fluorescent photosensitizer, and the photosensitizer has a unique non-planar conformation introduced by a selenophene unit, thereby enhancing aggregation-induced brightness and ROS efficiency.
[0011] Preferably, the compound AS4Se is prepared into AS4Se NPs as a NIR-II fluorescent photosensitizer with aggregation-induced reactive oxygen efficiency enhancement properties.
[0012] Preferably, the compound AS4Se is encapsulated in an amphiphilic polymer by a nano-coprecipitation method to prepare water-soluble AS4Se NPs, wherein the amphiphilic polymer includes DSPE-PEG and Pluronic F-127, and the molecular weight of PEG is 1000 to 10000.
[0013] Preferably, AS4Se NPs are synthesized by nano-coprecipitation method, and the mixed solvent is a combination of chloroform and tetrahydrofuran 1 mL, which is used to dissolve the compound AS4Se 1 mg and DSPE-PEG 2000 5 mg; then 1 mL of the obtained solution was injected into 10 mL of ultrapure water and sonicated for 2 minutes using a probe sonicator. At room temperature, after the organic solvent evaporated, the solution was filtered through a 0.22 μm filter head and concentrated using a filter membrane with a molecular weight of 30 kDa to obtain AS4Se NPs.
[0014] Preferably, the photosensitizer AS4Se NPs have excellent biocompatibility, can achieve significant accumulation at the tumor site, and can effectively eliminate the tumor only through photodynamic therapy.
[0015] Through its unique AD-A'-DA structural skeleton and peripheral selenophene groups, the molecule is given a non-planar conformation, showing a significant enhancement in fluorescence efficiency and ROS generation ability in the aggregated state. The AD-A'-DA structural skeleton has a fused ring core and two receptor units, ensuring a narrow band gap and high light capture ability. The incorporation of selenophene groups utilizes the heavy atom effect, improves the intersystem crossing ability, and enhances ROS generation. The presence of peripheral selenophene groups destroys the planarity of AS4Se and inhibits π-π stacking, thereby optimizing fluorescence and ROS generation. The compound AS4Se still has the above capabilities during the preparation of nanoparticles. AS4Se NPs perform well in photothermal properties, NIR-II fluorescence imaging, and single PDT treatment, providing a new path for the development of high-performance NIR-II fluorescent photosensitizers.
[0016] The compound AS4Se was synthesized by introducing four selenophene units into the molecular compound AS4H having an acceptor-donor-acceptor-donor-acceptor (AD-A'-DA) structure. The structural formula of the compound AS4H is as follows:
[0017]
[0018] In order to solve the above technical problems, another technical solution proposed by the present invention is: the application of the NIR-II fluorescent photosensitizer with the characteristics of enhancing the efficiency of aggregation-induced reactive oxygen species, the NIR-II fluorescent photosensitizer is used to prepare tumor optical diagnostic and therapeutic drugs, the NIR-II fluorescent photosensitizer has excellent biocompatibility, can achieve significant accumulation at the tumor site, and can effectively eliminate the tumor only through photodynamic therapy.
[0019] Beneficial effects of the present invention:
[0020] The present invention proposes a highly efficient NIR-II fluorescent type I / II photosensitizer AS4Se NPs and confirms its effectiveness in NIR-II fluorescent image-guided photodynamic therapy. AS4Se can enhance ROS efficiency when aggregated and can overcome the ROS quenching effect caused by aggregation. The unique properties of AS4Se are utilized, and AS4Se shows enhanced ROS efficiency in the aggregated state compared with the dissolved state.
[0021] There are selenophene units around AS4Se, which induce a non-planar conformation of AS4Se. The non-planar conformation of AS4Se promotes the increase of intersystem crossing ability during aggregation, thereby enhancing the efficiency of aggregation-induced ROS. 9,10-Anthracenediyl-bis(methylene)dimalonic acid (ABDA), dihydrorhodamine 123 (DHR123) and coumarin were used as fluorescent indicators to monitor the ROS generation. 1 O2, O2 •− and •OH. Silicon 2,3-naphthoic acid bis(trihexylsiloxane) (SiNc) was reacted in N,N-dimethylformamide (DMF, Φ Δ =32%) as a reference, quantitative analysis found that AS4Se NPs 1 O2 production rate ( Φ Δ ) is 14.0%, which is the highest reported value among all NIR-II fluorescent photosensitizers that can be excited above 800 nm.
[0022] In addition, AS4Se NPs Φ ΔThe results showed that AS4Se can enhance the ROS efficiency when aggregated and overcome the quenching effect of ROS generation caused by aggregation. Under laser irradiation, the presence of AS4Se NPs led to a significant enhancement in the fluorescence of the solution containing DHR123, while the solution containing coumarin did not show a significant fluorescence enhancement. These observations indicate that AS4Se NPs can generate O2 •− Compared with the previously reported type I NIR-II fluorescent photosensitizer (DCTBT NPs) with the same 808 nm absorption, the O2 generated by AS4Se NPs after 2 min of irradiation was •− It is about 22 times that of DCTBTNPs.
[0023] In addition, AS4Se has the benefit of enhanced aggregation-induced fluorescence efficiency. UV-visible-near-infrared spectroscopy revealed that AS4Se NPs exhibited enhanced absorption in the near-infrared region, with an extinction coefficient of 41 L g at a peak wavelength of 773 nm. −1 cm −1 or 91500 L mol −1 cm −1 , indicating a strong light-harvesting ability. Using indocyanine green (ICG) in DMSO as a reference, the fluorescence quantum yield of AS4Se NPs is 9.7% in the entire spectral range and 3.4% in the NIR-II region. Due to the high extinction coefficient and high NIR-II fluorescence quantum yield, the brightness of AS4Se NPs in the NIR-II region is about 6 times that of ICG / FBS (a proven bright NIR-II fluorophore) at the same mass concentration. Moreover, AS4Se NPs exhibit excellent photostability under continuous laser irradiation.
[0024] In summary, by utilizing the unique properties of AS4Se, namely, aggregation-induced fluorescence efficiency and enhanced ROS efficiency, AS4SeNPs as optical diagnostic and therapeutic agents have both high NIR-II brightness and excellent type I and type II photodynamic properties. This unique combination of properties is extremely rare in other NIR-II fluorescent photosensitizers. The present invention provides a new method for the development of NIR-II fluorescent photosensitizers for efficient tumor optical diagnosis and treatment, especially in optimizing their fluorescence brightness and enhancing photodynamic effects. The present invention not only reveals the excellent fluorescence properties and ROS generation ability of AS4Se NPs in the NIR-II spectral region, but also demonstrates how to enhance their photothermal effects and optical imaging capabilities by adjusting molecular design. This lays the foundation for the future development of more efficient and accurate optical diagnostic and therapeutic tools, especially in improving the sensitivity and selectivity of tumor detection and treatment, and has important practical application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] The present invention will be further described below in conjunction with the accompanying drawings.
[0026] Figure 1 This is a dynamic light scattering diagram of AS4Se in Example 2 of the present invention in a toluene / DMSO mixture with different DMSO concentrations.
[0027] Figure 2 (a) is the absorption spectrum of AS4Se in toluene / DMSO mixtures with different DMSO concentrations in Example 3 of the present invention; (b) is the emission spectrum of AS4Se in toluene / DMSO mixtures with different DMSO concentrations; (c) is the ratio of brightness to absorption (B / A) of AS4Se in toluene / DMSO mixtures with different DMSO concentrations.
[0028] Figure 3 is the fluorescence quantum yield of AS4Se in Example 3 of the present invention in solvents of different polarities.
[0029] Figure 4 (a) is the absorption spectrum of AS4H in toluene / DMSO mixtures with different DMSO concentrations in Example 3 of the present invention; (b) is the emission spectrum of AS4H in toluene / DMSO mixtures with different DMSO concentrations; (c) is the ratio of brightness to absorption (B / A) of AS4H in toluene / DMSO mixtures with different DMSO concentrations.
[0030] Figure 5 is the singlet oxygen quantum yield of AS4Se in Example 4 of the present invention in a toluene-DMSO mixture with different DMSO concentrations.
[0031] Figure 6 is the singlet oxygen quantum yield of AS4Se in different solvents in Example 4 of the present invention.
[0032] Figure 7 is the singlet oxygen quantum yield of AS4H in toluene-DMSO mixture with different DMSO concentrations in Example 4 of the present invention.
[0033] Figure 8 This is the optimized configuration of AS4Se single molecule and dimer in Example 5 of the present invention.
[0034] Fig. 9 This is the optimized configuration of AS4H single molecule and dimer in Example 5 of the present invention.
[0035] Fig.10 These are the possible intersystem crossing channels and corresponding R values of AS4Se single molecules and dimers in Example 6 of the present invention. These R values can be used to indicate the intersystem crossing rate.
[0036] Fig.11These are the possible intersystem crossing channels and corresponding R values of AS4H single molecules and dimers in Example 6 of the present invention. These R values can be used to indicate the intersystem crossing rate.
[0037] Fig.12 The singlet and triplet energy level distributions of AS4Se in monomer and dimer forms in Example 6 of the present invention.
[0038] Fig.13 This is the potential diagram of AS4Se measured by cyclic voltammetry in Example 6 of the present invention.
[0039] Fig.14 is the Gibbs free energy change of AS4Se in Example 6 of the present invention.
[0040] Fig.15 In Example 7 of the present invention, f DMSO = 90%, absorption diagram of aggregates formed by AS4Se in solutions with different concentrations.
[0041] Fig.16 (a) is the UV-Vis-NIR spectrum of AS4Se in Example 9 of the present invention in chloroform with different concentrations; (b) is the relationship between the absorbance of AS4Se at 739 nm and the concentration of AS4Se in chloroform; (c) is the absorption spectrum of AS4Se NPs in water; (d) is the corresponding absorption spectrum of AS4Se NPs in chloroform (n = 3).
[0042] Fig.17 (a) is the absorption spectrum of AS4Se NPs in Example 10 of the present invention at different concentrations in water; (b) is the photoluminescence (PL) spectrum of AS4Se NPs under 780 nm excitation; (c) is the relationship between the fluorescence integrated area and the absorbance intensity at 780 nm; (d) is the relationship between the fluorescence integrated area over 1000 nm and the absorbance intensity at 780 nm based on the measurement of (c).
[0043] Fig.18 (a) is the ABDA absorption spectrum of AS4Se NPs in water in Example 11 of the present invention, which is used to detect 1 O2. (b) Degradation rate of ABDA at 378 nm caused by AS4Se NPs, as well as the degradation rate of SiNc in DMF as a reference and the corresponding singlet oxygen generation rate of AS4Se NPs.
[0044] Fig.19 The fluorescence spectrum of the mixed solution of AS4Se NPs and DHR123 under continuous laser irradiation (808 nm) in Example 12 of the present invention is used to detect O2•− .
[0045] Fig. 20 This is the fluorescence spectrum of the mixed solution of AS4Se NPs and coumarin under continuous laser irradiation (808 nm) in Example 12 of the present invention, which is used to detect •OH.
[0046] Fig.21 is the fluorescence enhancement factor of DHR123 of AS4Se NPs and DCTBT NPs (as a reference) in Example 12 of the present invention, both of which have the same absorbance at 808 nm. I0 and I respectively represent the fluorescence intensity of DHR123 in the presence of AS4Se NPs or DCTBT NPs before and after laser irradiation at different times.
[0047] Fig. 22 This is a confocal fluorescence image of 4T1 cells co-cultured with AS4Se / BD NPs in Example 13 of the present invention, using Mito-tracker Deep Red and Lyso-Tracker Green for co-staining.
[0048] Fig.23 (a) is the evaluation of the cytotoxicity of AS4SeNPs to 4T1 cells by CCK-8 method under normoxic and hypoxic conditions in Example 14 of the present invention. (b) is the confocal fluorescence image of 4T1 cells after different treatments under normoxic and hypoxic conditions, followed by live and dead cell staining using Calcein-AM and PI, respectively.
[0049] Fig.24 DCFH-DA was used as a fluorescent probe to characterize the intracellular ROS generation ability of AS4Se NPs under normoxic and hypoxic conditions in Example 15 of the present invention. The green fluorescence comes from DCFH, indicating the generation of intracellular ROS.
[0050] Fig.25 This is a near-infrared II (NIR-II) fluorescence image of a tumor-bearing mouse in Example 16 of the present invention.
[0051] Fig.26 This is the in vitro NIR-II fluorescence image of mouse tumors and other organs in Example 16 of the present invention.
[0052] Fig. 27 The corresponding temperature change of the tumor site of the mouse carrying 4T1 tumor under 808 nm laser irradiation in Example 17 of the present invention.
[0053] Fig.28 In Example 17 of the present invention, after 14 days of phototherapy, the (a) tumor volume, (b) tumor photo, and (c) tumor weight of the mice were measured.
[0054] Fig.29 H&E staining and Ki-67 staining of tumor tissues of mice sacrificed on the 14th day after photodynamic therapy (PDT) treatment in Example 17 of the present invention. DETAILED DESCRIPTION Example 1
[0055] The preparation steps of compound AS4Se are as follows:
[0056]
[0057] Reagents and conditions used in the synthesis route of AS4Se: i) 2-(4,7-dibromo-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile, pyridine, chloroform, 56°C, 10h; ii) (selenopyridine-2-yl)tributylstannane, tris(dibenzylideneacetone)dipalladium(0), tris(o-methylphenyl)phosphine, toluene, 100°C, 5h.
[0058] Synthesis of AS4Br: Compound 1 (250 mg, 0.18 mmol) and 2-(5-bromo-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile (250 mg, 0.71 mmol) were dissolved in chloroform (50 mL), and pyridine (0.5 mL) was added under an argon atmosphere. The reaction mixture was stirred at 56 ° C for 10 hours. After cooling to room temperature, the reaction mixture was poured into methanol to cause the crude product to precipitate, which was then collected by filtration. The crude product was further purified by silica gel column chromatography (eluent: petroleum ether / dichloromethane = 7 / 3), and AS4Br was finally obtained as a dark blue solid (300 mg, yield: 80%). 1H NMR (400 MHz, CDCl3, δ): 9.17 (s, 2H), 8.93 (s, 2H), 8.11 (s, 2H), 4.77 (d, 4H), 3.22 (t, 4H), 2.16–2.06 (m, 2H), 1.91–1.82 (m, 4H), 1.54–1.47 (m, 4H), 1.37–0.99 (m,92H), 0.87 (m, 6H), 0.83 (m, 6H), 0.78 (m, 6H). 13C NMR (100 MHz, CDCl3, δ): 186.31, 158.72, 154.21, 147.61, 145.46, 39.96, 29.77, 29.72, 29.68, 29.63, 29.59, 29.57, 29.50, 29.37, 25.77, 22.84,22.78, 14.29.
[0059] Synthesis of AS4Se: AS4Br (100 mg, 0.05 mmol), tris(dibenzylideneacetone)dipalladium(0) (15 mg, 0.02 mmol) and tris(o-methylphenyl)phosphine (15 mg, 0.05 mmol) were dissolved in toluene (50 mL), and then (selenopyridine-2-yl)tributylstannane z (200 mg, 0.48 mmol) was added. The reaction mixture was heated to 100 °C under an argon atmosphere and reacted for 5 hours. Subsequently, the mixture was cooled to room temperature. After removing the solvent, the residue was dissolved in dichloromethane and washed with water. The obtained organic phase was dried over Na2SO4 and then filtered. After the filtrate was concentrated, it was further purified using silica gel column chromatography (eluent: petroleum ether / dichloromethane = 7 / 3) to finally obtain AS4Se as a dark solid (80 mg, yield: 71.4%). 1H NMR (400MHz, CDCl3, δ): 9.18 (s, 2H), 8.83 (d, 2H), 8.15 (m, 4H), 8.03 (s, 2H), 7.38(m, 4H), 7.32–7.27 (m, 4H), 4.76 (d, 4H), 3.25 (t, 4H), 2.18–2.08 (m, 2H), 1.94–1.85 (m, 4H), 1.54–1.47 (m, 4H), 1.41–0.94 (m, 92H), 0.87 (t, 6H), 0.81(t, 6H), 0.76 (t, 6H). 13C NMR (100 MHz, CDCl3, δ): 137.97, 160.19, 153.27,147.54, 146.90, 146.78, 145.14, 142.45, 141.95, 138.77, 137.97, 135.78,135.62, 135.04, 134.83, 133.95, 133.60, 131.65, 131.51, 130.32, 129.97,129.91, 127.20, 125.15, 121.47, 115.54, 115.11, 113.64, 67.96, 39.14, 32.05,31.93, 31.35, 30.56, 30.05, 29.91, 29.83, 29.78, 29.73, 29.70, 29.65, 29.57,29.50, 29.47, 29.34, 25.64, 22.83, 22.74, 14.28.
[0060] Example 2
[0061] Preparation of AS4Se nanoaggregates in toluene-DMSO mixture: First, a 0.5 mg mL −1 The AS4Se toluene stock solution was prepared and then dispensed into test tubes. Then, an appropriate amount of blank toluene was added as needed, and then DMSO was added in a certain proportion to reach a final solution volume of 2 mL. The mixture was vigorously mixed on an oscillator, and the DMSO volume fraction in toluene ( f DMSO ) ranged from 0% to 90%. Once prepared, the mixture was immediately used for subsequent measurements. In addition, a similar procedure was used for the preparation of AS4H nanoaggregates in a toluene-DMSO mixture. Since non-polar toluene is a good solvent for AS4Se, while polar DMSO is a poor solvent for AS4Se, the polarity of the solvent and the degree of aggregation can be effectively adjusted by adjusting the ratio of DMSO in toluene, which can be verified by dynamic light scattering experiments. Under the test concentration conditions, only f DMSO Aggregates can only be formed when the ratio increases to more than 60% ( Figure 1 ).
[0062] Example 3
[0063] Evaluation of the fluorescence efficiency of AS4Se in toluene / DMSO mixture: Following the above procedure, the absorption and emission spectra of AS4Se in toluene / DMSO mixture (excitation wavelength: 730 nm) were measured immediately after preparation. Figure 2 Middle (a), Figure 2 (b). The fluorescence efficiency was then roughly evaluated by calculating the brightness to absorption (B / A) ratio. Figure 2 (c). Brightness is determined by integrating the fluorescence intensity over the entire spectrum, while absorption is based on the absorbance of AS4Se at the excitation wavelength. f DMSO In the process of increasing from 0 to 60%, the B / A value of AS4Se first increases and then decreases, which is consistent with the trend of its fluorescence quantum yield shifting from non-polar solvent to polar solvent ( Figure 3 ), this phenomenon and the above-mentioned dynamic light scattering test results together indicate that the fluorescence quantum yield at this stage is mainly affected by the polarity of the solvent. f DMSO With further increase in the fluorescence intensity (aggregation begins to form), the B / A value increases again, which indicates that AS4Se has the characteristic of "aggregation-induced luminescence efficiency enhancement". At the same time, for comparison, we also tested the fluorescence efficiency of AS4H in a toluene / DMSO mixture under the same conditions. Figure 4 Middle (a), Figure 4 Middle (b), Figure 4(c) AS4H in the aggregated state shows a phenomenon of aggregation leading to reduced luminescence efficiency.
[0064] The structural formula of the compound AS4H is as follows:
[0065]
[0066] Example 4
[0067] The singlet oxygen yield of AS4Se in toluene-DMSO mixture ( Φ Δ ) Evaluation: The relative singlet quantum yield of AS4Se in the above toluene-DMSO mixture was determined using SiNc as a reference. Diphenylisobenzofuran (DPBF) was used as an indicator and the concentration was 1 mg mL -1 The concentration of DPBF was dissolved in toluene to form a stock solution. 10 μL of DPBF was added to the toluene-DMSO mixture, followed by continuous laser irradiation at a wavelength of 730 nm. The absorption of DPBF at 416 nm was monitored to calculate the decay rate of the photosensitization process ( Figure 5 ). Similar to the change trend of B / A value, when f DMSO This is consistent with the trend of the active oxygen production rate shifting from non-polar solvent to polar solvent ( Figure 6 ), with the formation of aggregates, AS4Se exhibits “aggregation-induced reactive oxygen species (at least 1 The singlet oxygen yield of AS4Se in a toluene-DMSO mixture was determined by the following formula:
[0068]
[0069] in Φ Δ is the singlet oxygen yield, S is the slope of the graph of DPBF (416 nm) absorption intensity versus irradiation time, F is the absorbance correction factor, calculated as F = 1 – 10 −OD (OD represents absorbance at 730 nm), ref and sam represent SiNc and AS4Se, respectively. Similarly, AS4H showed aggregation in toluene-DMSO mixture, resulting in a decrease in the production of active oxygen ( Figure 7 ).
[0070] Example 5
[0071] Taking the AS4Se dimer as an example, the following comparative analysis is made with the single molecule AS4Se: Theoretical calculations of the AS4Se molecular structure were performed at the B3LYP / 6-31G (d,p) level to study the single molecule and dimer forms of AS4Se. In order to save calculation time, the alkyl group was replaced by the methyl group. Figure 8 As shown in Figure 2, AS4Se exhibits a non-planar conformation due to the presence of the selenophene unit. The introduction of the selenophene unit causes the structure of the acceptor unit to be distorted, causing the malononitrile group and the remaining groups to deviate in the opposite direction of the plane of the central condensed ring core within the acceptor unit. There is a certain dihedral angle (between 29.8 and 39.1 degrees) between the selenophene unit and the phenyl group in the acceptor unit. This is in contrast to the calculated results of the AS4H molecule, as shown in Figure 2. Fig. 9 As shown in Figure 2, they have a similar backbone but lack the peripheral selenophene unit, the acceptor unit is planar, and the dihedral angle between the fused ring core and the acceptor unit is small. The non-planar conformation of AS4Se allows for minimal overlap between the acceptor units when forming dimers. Frontier molecular orbital analysis shows that in the excited state, electron density is transferred from the fused ring core to the monomer acceptor unit of AS4Se, or from the monomer to another monomer in its dimer form. The enhanced separation of frontier molecular orbitals from monomer to dimer helps to reduce the energy gap (Δ E ST ), which helps to promote the enhancement of the intersystem crossing (ISC) process.
[0072] Example 6
[0073] Taking the AS4Se dimer as an example, we made the following comparative analysis with the single-molecule AS4Se: Based on the optimized geometric structure, we used the ORCA 4.1 package to perform further theoretical calculations on the inter-system crossing process. As AS4Se transforms from a monomer to a dimer, the energy level distribution of the singlet and triplet states becomes more dense, which is due to the orbital overlap between monomers ( Fig.10 This increase in energy level density has been shown to contribute to the reduction of the first excited singlet state ( S 1) and the excited triplet state ( T n ), thus promoting the increase of potential ISC. Fig.11 As shown, from S 1 to T m The transitions of (m = 2–5) were identified as the main ISC channels in AS4Se monomers, and their energy gap is less than 0.3 eV, which is the critical threshold for promoting efficient intersystem crossing. In contrast, more potential ISC channels were identified in dimer AS4Se, from S 1 to T m(m = 3–10). However, for the control compound AS4H, its dimer state also showed more ISC channels than the monomer state (2 for monomer AS4H and 4 for dimer AS4H), but still less than the number of dimer channels of AS4Se ( Fig.12 ).based on k ISC Proportional to the R value, we estimated the intersystem crossing rate ( k ISC ), where the expression of R is R (R = [< S n ǀ ĤSOǀ T m > / Δ E ST ] 2 × 10 7 , and the R value is dimensionless. The increase in the number of potential ISC channels and k ISC The increase in ROS efficiency is not sufficient to explain the opposite trend observed in the aggregation of AS4Se and AS4H. It is well known that the energy of excited states can be transferred through various channels including phosphorescence, internal conversion, intersystem crossing (e.g., T 1 to S 0) and photochemical reactions (e.g., ROS generation) to return to the ground state. Given that aggregates of AS4Se and AS4H do not produce phosphorescence, the observed difference in ROS efficiency between them is likely due to the differences in their internal conversion and intersystem transition processes. Therefore, it is reasonable to infer that in the aggregated state, the unique non-planar conformation of AS4Se preferentially inhibits the decay of triplet excitation energy back to the ground state through internal conversion and intersystem transition pathways, while this is not the case for AS4H. This inhibition, in turn, mainly promotes the decay of triplet excitation energy through the generation of ROS, which, combined with the enhanced ISC process, collectively endows AS4Se with aggregation-induced ROS efficiency enhancement properties. In addition to the ISC process, energy levels also need to meet specific requirements for the generation of ROS. In type II PDT, T The energy level of 1 must exceed the oxygen sensitivity threshold of approximately 0.96 eV. Fig.13 As shown, the monomer and dimer AS4Se T 1 energy levels are 1.231 eV and approximately 1.228 eV, respectively, which provides sufficient energy to sensitize O2 generation 1 O2. In type I PDT, O2 / O2 •− and H2O / •OH at pH = 7 have redox potentials of −0.33 V and 1.99 V, respectively. E C ) and valence band ( EV ) must have energy levels less than −0.33 eV and greater than 1.99 eV, respectively, to produce O2 •− and •OH. Electrochemical cyclic voltammetry measurements of AS4Se were performed using an electrochemical analyzer (CHI630E, CH Instrument). The standard three-electrode system used included an Ag / AgCl reference electrode, a platinum wire pair electrode, and a glassy carbon electrode coated with an AS4Se film as the working electrode. A ferrocene / ferrocenium redox couple was used as an internal standard. Cyclic voltammograms ( Fig.15 ). E C (−0.50 eV) and E V (1.22 eV) energy level indicates that AS4Se has the ability to generate O2 •− The potential of O2 •− The generation of depends on the efficient electron transfer process from AS4Se to O2, which can be expressed by the Gibbs free energy change ( ΔG ). According to previous studies, ΔG The calculation of the simplified Rehm-Weller equation ( ΔG = E ox − E red − E 0–0 ),in E ox represents the oxidation potential of AS4Se, E red represents the reduction potential of ground state oxygen, both of which are referenced to the standard hydrogen electrode. In addition, E 0–0 corresponds to the energy of the lowest excited state of AS4Se. Fig.14 As shown, ΔG = −10.1 kJ mol −1 , the negative ΔG value indicates that the electron transfer process is thermodynamically feasible.
[0074] Example 7
[0075] In order to verify the hypothesis that the formation of aggregates is independent of concentration within a certain range, we f DMSO = 90%, AS4Se in a certain concentration range (1 to 20 μg mL -1The results showed that AS4Se has a strong absorption capacity in the solution of 2.5 % and 1.5 % respectively. f DMSO = 90% when the position of the absorption band remains essentially unchanged ( Fig.15 ). This finding confirms that the characteristics of the aggregates formed by AS4Se in solutions of different concentrations are consistent and are not affected by concentration. Therefore, in the subsequent nanoparticle preparation process, the effect of concentration on the formation and performance of aggregates can be ignored.
[0076] Example 8
[0077] Since the obtained compound AS4Se has strong lipophilicity, it cannot be directly applied to the biological environment. Therefore, the nano-coprecipitation method is used to encapsulate it in amphiphilic polymers with good biocompatibility, such as DSPE-PEG (PEG length is adjustable, PEG molecular weight is 1000-10000), Pluronic F-127, etc. AS4Se NPs are prepared by nano-precipitation. 2000 The nanoparticles were prepared by taking the matrix as an example. The operation steps were as follows: a mixed solvent (1 mL) containing chloroform and tetrahydrofuran was used in a volume ratio of 1:4 to dissolve AS4Se (1 mg) and DSPE-PEG 2000 (5 mg). Subsequently, the resulting solution was injected into 10 mL of ultrapure water and sonicated for 2 min using a probe sonicator. The organic solvent was evaporated in a fume hood at room temperature, and then the solution was filtered through a 0.2 μm pore size filter and concentrated using a 30 kDa molecular weight cutoff membrane to obtain AS4Se NPs for further use.
[0078] Example 9
[0079] Extinction coefficient measurement of AS4Se NPs in water The method to determine the extinction coefficient of AS4Se NPs in water consists of three steps.
[0080] (i) Measurement of the mass extinction coefficient of AS4Se in chloroform. Briefly, using a chloroform stock solution of AS4Se at a concentration of 100 μg / mL, samples of different concentrations (2.5, 5.0, 7.5, 10, and 12.5 μg / mL) were prepared by diluting chloroform. These samples were then used to measure absorption spectra, thereby determining the extinction coefficient of AS4Se in chloroform by plotting the absorption intensity of AS4Se at a specific wavelength versus concentration. The slope represents the mass extinction coefficient of AS4Se in chloroform at a specific wavelength. Fig.16 Middle (a), Fig.16 Middle (b). Fig.16(a) shows the UV-Vis-NIR spectra of AS4Se in chloroform with different concentrations. Fig.16 (b) Relationship between the absorbance of AS4Se at 739 nm and the concentration of AS4Se in chloroform; Fig.16 The slope of (b) corresponds to the mass extinction coefficient of AS4Se in chloroform at 739 nm (99.6 L g ‒1 cm ‒1 ).
[0081] (ii) Measurement of the absorption spectra of AS4Se NPs in water and samples prepared by dissolving freeze-dried AS4Se NPs in chloroform. Initially, the aqueous solution of AS4Se NPs was divided into four samples of equal volume. One sample was used to measure the absorption spectrum, Fig.16 (c), while the remaining three samples were freeze-dried and vacuum-dried. The obtained powders were then dissolved in chloroform in an equal volume to the original aqueous solution, and the absorption spectra of these solutions were measured. Fig.16 According to the extinction coefficient of AS4Se in chloroform described in step (i), the actual concentration of AS4Se in the above four water samples can be determined according to the Beer-Lambert law: A = εcl .here, A represents the average absorbance of the lyophilized powder redissolved in chloroform, c represents the actual concentration of AS4Se in the above four water samples, l is the optical path length (1 cm).
[0082] (iii) Calculate the extinction coefficient of AS4Se NPs in water. Specifically, using the absorption spectrum data of AS4Se NPs in water and the actual concentration of AS4Se described in step (ii), the mass extinction coefficient of AS4Se NPs in water can be determined according to the Beer-Lambert law. In addition, the molar extinction coefficient of AS4Se NPs at a specific wavelength can be calculated by multiplying the mass extinction coefficient by the molecular weight of AS4Se. The results showed that AS4Se NPs exhibited enhanced absorption in the near-infrared region, with an extinction coefficient of 41 L g at a peak wavelength of 773 nm. −1 cm −1 or 91500 L mol −1 cm −1 , indicating its strong light-harvesting ability.
[0083] Example 10
[0084] The fluorescence quantum yield (QY) of AS4Se NPs was determined by the following method, with ICG as the reference (QY = 6.0% in DMSO over 900 nm). ICG was diluted with DMSO to prepare a series of samples with an absorbance intensity of no more than 0.1 at 780 nm. The emission spectrum was then integrated over the 800 to 1500 nm region. The same treatment was performed on AS4Se NPs in water. The obtained emission integral value was plotted against the absorbance intensity. Fig.17 Middle (a), Fig.17 Middle (b), Fig.17 (a) and fitted into a linear relationship. The calculation formula of QY is as follows:
[0085]
[0086] in, ST and X represent standard samples and test samples respectively, QY represents the fluorescence quantum yield, Grad is the gradient obtained from the integrated fluorescence intensity versus absorbance plot, η represents the refractive index of the solvent, ref Indicates ICG, sam Denotes AS4Se. Due to the high extinction coefficient and high NIR-II fluorescence quantum yield, the brightness of AS4Se NPs in the NIR-II region is about 6 times that of ICG / FBS.
[0087] Embodiment 11
[0088] Singlet oxygen ( 1 O2) generation ability evaluation: 9,10-Anthracenediyl-bis(methylene)dicarboxylic acid (ABDA) was used as an indicator to evaluate the O2 generation ability of AS4Se NPs. 1 O2 generation capacity. Specifically, ABDA (10 μL, 20 mM) in DMSO was added to AS4Se NPs (2 mL, 12 μg mL −1 ), the absorbance was about 0.5 and the wavelength was 808 nm. Subsequently, the sample was continuously irradiated with laser light at a wavelength of 808 nm (100 mW cm −2 ) and record the absorption spectra at specific time intervals, Fig.18 (a). By plotting the change curve of the sample's absorbance intensity at 378 nm wavelength versus laser irradiation time, Fig.18 In (b), the AS4Se NPs were quantitatively determined. 1The O2 quantum yield is 14.0%. SiNc was chosen as a reference (SiNc in DMF has a 1O2 quantum yield of 32%). To the best of our knowledge, this value represents the highest reported value that can be excited above 800 nm. During the measurement, the excitation wavelength was 781 nm. In addition, the AS4Se NPs Φ Δ Significantly higher than AS4Se in solution ( Figure 6 ), which further confirmed that AS4Se could enhance ROS efficiency upon aggregation and overcome the ROS quenching effect caused by aggregation.
[0089] Example 12
[0090] Evaluation of the ability of AS4Se NPs as type I photosensitizers: coumarin and dihydrorhodamine 123 (DHR123) were used as fluorescent indicators to monitor •OH and O2, respectively. •− Coumarin (10 μL) and DHR123 (10 μL) were added to AS4Se NPs solution (2 mL, 12 μg mL −1 ), the absorbance of the solution at 808 nm was 0.5, and the mixed solution was illuminated by 808 nm laser (power density was 100 mW cm −2 ) were irradiated, and the fluorescence intensity of coumarin at 445 nm (excitation wavelength: 330 nm) and DHR123 at 525 nm (excitation wavelength: 480 nm) was measured. Fig.19 , Fig. 20 ). The results showed that AS4Se NPs have the ability to generate O2 •− In order to compare the O2 •− To increase the generation capacity, it is necessary to adjust their absorbance at 808 nm to the same before laser irradiation, such as Fig.21 As shown, the O2 generated by AS4Se NPs •− It is about 22 times that of DCTBT NPs.
[0091] Embodiment 13
[0092] Intracellular colocalization: Since conventional confocal fluorescence microscopy cannot detect the fluorescence of AS4Se NPs, we used a model nano-NPs, AS4Se / BD NPs, which mimic AS4Se NPs, to study the intracellular localization. The preparation method of AS4Se / BD was the same as that of AS4Se NPs, where AS4Se and BTPEBD were combined by coprecipitation. BTPEBD is a small molecule that has strong green fluorescence after being encapsulated into nanoparticles. 4T1 cells were cultured in a confocal dish at 37 °C overnight. Subsequently, 4T1 cells were incubated with AS4Se / BD NPs for different times. After washing the cells, the cells were treated with PBS and used for confocal fluorescence imaging. In addition, to determine the intracellular distribution of AS4Se / BD NPs, 4T1 cells were incubated with AS4Se / BDNPs (20 μg mL −1 After incubation for 24 hours, AS4Se / BD NPs were incubated with Lyso-Tracker Red and Mito-Tracker Deep Red for 1 hour, respectively. The cells were then washed with PBS and used for fluorescence imaging. The imaging data were analyzed using ImageJ software ( Fig. 22 ). Cell imaging results revealed that AS4Se NPs were effectively taken up by 4T1 cells and distributed in the cytoplasm, with some NPs accumulating in specific organelles such as mitochondria and lysosomes.
[0093] Embodiment 14
[0094] In vitro photocytotoxicity assay of AS4Se NPs. The in vitro photocytotoxicity of AS4Se NPs on 4T1 cells was evaluated using CCK-8 assay. Briefly, 4T1 cells were seeded in 96-well plates and incubated at 37 °C for 24 h. Subsequently, the culture medium was replaced with medium containing different concentrations of AS4Se NPs, ranging from 0 to 20 μg mL −1 After 24 h of incubation, cells were washed with PBS and then exposed to 808 nm laser irradiation (100 mW cm −2 , for 5 minutes). Subsequently, the cells were incubated for another 4 hours in the dark. CCK-8 assay was then performed according to the standard protocol. Fig.23 (a). The results showed that the cell activity decreased significantly under both normoxic and hypoxic conditions. In addition, to further confirm the photocytotoxicity of AS4Se NPs, 4T1 cells were treated with AS4Se NPs (20 μg mL −1 After 24 hours of incubation, Calcein-AM / PI cell staining was performed according to the instruction manual. Fig.23 In (b), the phototoxic effect of AS4Se NPs was further verified.
[0095] Embodiment 15
[0096] Intracellular 1 O2 production: 4T1 cells were plated at 5 × 10 4 The cells were seeded in 24-well plates at a density of 10 cells / mL and cultured for 12 h. Subsequently, the cells were treated with RPMI-1640 or AS4Se NPs (20 μg mL −1 ) for 12 h. After that, the medium was removed and the cells were washed once with PBS, and RPMI-1640 medium containing 10 μM DCFH-DA was added to the wells and incubated for another 30 min. Then, the cells were washed again with PBS and irradiated with laser for 5 min (808 nm, 100 mW cm −2 ), and the control group was not irradiated. Finally, an inverted fluorescence microscope (Nikon, Japan) was used to capture fluorescent cell images under 470 nm excitation ( Fig.24 ). Due to the low concentration of AS4Se NPs and the low laser power density, the photothermal effect was not obvious during laser irradiation, excluding the possibility of phototoxicity caused by this mechanism. However, the use of 2,7-dichlorodihydrofluorescein diacetate as a fluorescent indicator confirmed the generation of a large amount of ROS in cells, both under normoxic and hypoxic experimental conditions. Therefore, the significant photocytotoxicity of AS4Se NPs should be attributed only to the photodynamic effect.
[0097] Example 16
[0098] To determine the optimal time window for PDT experiments, AS4Se NPs (200 μL, 0.25 mg / mL) were injected intravenously. -1 ) and then NIR-II tumor fluorescence imaging. Female Balb / c mice (6 weeks old, 18 g) bearing subcutaneous 4T1 tumors were used for NIR-II fluorescence imaging. Briefly, AS4Se NPs (200 μL, 0.25 mg mL −1 ) was injected into mice via the tail vein. The mice were then imaged by the NIR-II fluorescence imaging system at predetermined time intervals. The excitation wavelength used was 808 nm (20 mW cm −2 ), imaging was performed using a 1000 nm long pass filter and an exposure time of 2 ms to collect signals ( Fig.25 ). Over time, the fluorescence signal at the tumor site gradually increased, reaching a peak within 12 to 48 hours after intravenous injection of AS4Se NPs. In addition, ex vivo fluorescence imaging of major organs 24 hours after injection of AS4Se NPs showed that the tumor exhibited significant fluorescence compared to all other organs ( Fig.26). These observations collectively indicate that AS4 NPs are efficiently accumulated within tumors and possess significant tumor targeting capabilities.
[0099] Embodiment 17
[0100] To investigate the antitumor effect of AS4Se NPs in vivo, mice bearing tumors were randomly divided into four treatment groups (n=5), including PBS+laser, AS4Se NPs, AS4Se NPs+laser+vitamin C (Vc), and AS4Se NPs+laser. The therapeutic agent was injected into the mice via the tail vein (200 μL, 0.25 mg mL −1 Given that AS4Se NPs exhibit excellent type I and type II photodynamic properties, only low power densities (100 mW cm −2 , 20 minutes) of laser, during which the temperature of the tumor site increased slightly (ΔT < 3°C) ( Fig. 27 ), indicating that AS4Se NPs did not induce any significant thermal effect, excluding the contribution of photothermal therapy to the therapeutic effect. During the 14 days of treatment, the changes in tumor volume were recorded accordingly. Fig.28 Middle (a). Tumor volume measured by caliper is calculated as follows: Volume = (tumor length) × (tumor width) 2 / 2, in both the PBS + laser and AS4Se NPs groups, the tumor volume increased significantly, indicating that the tumor grew rapidly and that AS4Se NPs themselves had little antitumor effect. In contrast, the AS4Se NPs + laser group significantly inhibited tumor growth, as shown by the smallest tumor volume. In addition, the presence of vitamin C slightly reduced the therapeutic effect of the AS4Se NPs + laser + Vc group, resulting in a larger tumor volume than the AS4Se NPs + laser group, because Vc hindered the effect of PDT to some extent. The data from the photos and tumor weights further confirmed that Fig.28 Middle (b), Fig.28 In (c), AS4Se NPs+laser has the most effective antitumor effect. 14 days after photodynamic therapy, tumors and major organs were removed from mice for further analysis. Hematoxylin and eosin (H&E) staining of tumor sections clearly showed ( Fig.29 ), extensive destruction of tumor tissue was observed in the AS4Se NPs+laser group, while tumor cells in the PBS+laser group and the AS4Se NPs group were closely arranged and had normal morphology. Ki67 immunofluorescence staining further verified the excellent anti-tumor efficacy of the AS4Se NPs+laser group ( Fig.29). Among the four treatment groups, the AS4Se NPs+laser group had the weakest green fluorescence, indicating that the percentage of proliferating tumor cells decreased the most.
[0101] The present invention is not limited to the specific technical solutions described in the above embodiments, and all technical solutions formed by equivalent replacement are within the protection scope required by the present invention.
Claims
1. A compound, Features: The structural formula of compound AS4Se is as follows: 。 2. A method for preparing the compound according to claim 1, Features: The synthetic route of compound AS4Se is as follows: ; The reagents and conditions used in the synthesis route of AS4Se: i) 2-(4,7-dibromo-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile, pyridine, chloroform, 56°C, 10h; ii) (seleno-2-yl)tributylstannane, tris(dibenzylideneacetone)dipalladium(0), tris(o-methylphenyl)phosphine, toluene, 100°C, 5h.
3. A NIR-II fluorescent photosensitizer having aggregation-induced reactive oxygen efficiency enhancement characteristics prepared from the compound according to claim 1, Features: The compound AS4Se is used to prepare a near-infrared second-zone fluorescent photosensitizer, and the photosensitizer has a unique non-planar conformation introduced by a selenophene unit, thereby enhancing aggregation-induced brightness and ROS efficiency; the compound AS4Se is prepared into nanoparticles AS4Se NPs as a near-infrared second-zone fluorescent photosensitizer; the AS4Se NPs are synthesized by a nanocoprecipitation method, and a mixed solvent of 1 mL of a combination of chloroform and tetrahydrofuran is used to dissolve 1 mg of the compound AS4Se and DSPE-PEG 2000 5 mg; then 1 mL of the obtained solution was injected into 10 mL of ultrapure water and sonicated for 2 minutes using a probe sonicator. At room temperature, after the organic solvent evaporated, the solution was filtered through a 0.22 μm filter head and concentrated using a filter membrane with a molecular weight of 30 kDa to obtain AS4Se NPs.
4. The use of the NIR-II fluorescent photosensitizer having aggregation-induced reactive oxygen efficiency enhancement characteristics according to claim 3, Features: The photosensitizer is used for preparing tumor optical diagnosis and treatment drugs.
